Improvement in Vision-Related Function with Intravitreal Aflibercept
- 1 March 2015
- journal article
- research article
- Published by Elsevier in Ophthalmology
- Vol. 122 (3) , 571-578
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Assessing quality of life in the treatment of patients with age-related macular degeneration: clinical research findings and recommendations for clinical practiceClinical Ophthalmology, 2013
- Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular DegenerationOphthalmology, 2012
- Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumabAngiogenesis, 2012
- Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in Age-Related Macular DegenerationInvestigative Ophthalmology & Visual Science, 2011
- Association between Changes in Visual Acuity and Vision-Related Quality of Life in Japanese Patients with Low VisionOphthalmic Research, 2010
- The Psychometric Validity of the NEI VFQ-25 for Use in a Low-Vision PopulationInvestigative Ophthalmology & Visual Science, 2010
- Age-Related Macular DegenerationNew England Journal of Medicine, 2008
- Predicted biological activity of intravitreal VEGF TrapBritish Journal of Ophthalmology, 2008
- Quality of life in patients with age-related macular degeneration: results from the VISION studyEye, 2007
- Burden of illness, visual impairment and health resource utilisation of patients with neovascular age-related macular degeneration: results from the UK cohort of a five-country cross-sectional studyBritish Journal of Ophthalmology, 2007